INS and Hypoglycemia: In level 1 hypoglycemia, level 2 or 3 hypoglycemia, injection-site reaction, hypersensitivity event, and any adverse event probably or possibly related to basal insulin, there was no statistical difference between Icodec and once-daily insulin.